RBC
NUVA

Roble Belko & Company’s NuVasive, Inc. NUVA Stock Holding History

Roble Belko & Company’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-77
Closed -$4K – 330
2018
Q4 		$4K Hold
77
– – ﹤0.01% 263
2018
Q3 		$5K Hold
77
– – ﹤0.01% 270
2018
Q2 		$4K Hold
77
– – ﹤0.01% 285
2018
Q1 		$4K Hold
77
– – ﹤0.01% 287
2017
Q4 		$5K Hold
77
– – ﹤0.01% 266
2017
Q3 		$4K Hold
77
– – ﹤0.01% 238
2017
Q2 		$6K Hold
77
– – ﹤0.01% 226
2017
Q1 		$6K Hold
77
– – ﹤0.01% 253
2016
Q4 		$5K Buy
+77
New +$4.96K ﹤0.01% 279

Other funds holding NUVA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Roble Belko & Company's NUVA Position: Q1 2019 in Review

Roble Belko & Company sold out of NuVasive, Inc. (NUVA) in Q1 2019, closing a stake of 77 shares — an estimated $4K sold.

Roble Belko & Company first reported a position in NUVA in Q4 2016 and held it in 9 quarters. The position peaked at $6K in Q2 2017. 255 funds tracked by Wall St. Rank hold NUVA as of Q1 2019.

  • Roble Belko & Company reported no remaining NuVasive, Inc. position as of Q1 2019 after selling out during the quarter.
  • Roble Belko & Company sold 77 NuVasive, Inc. shares in Q1 2019, an estimated $4K.
  • Roble Belko & Company first reported a position in NuVasive, Inc. in Q4 2016 and held it in 9 quarters.
  • Roble Belko & Company's NuVasive, Inc. position peaked at $6K in Q2 2017.
  • 255 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2019.

Based on Roble Belko & Company's 13F filing for Q1 2019, filed 10 May 2019.